Dose escalation for prostate cancer: which dose for which person?
Sandler
Howard M
HM
Department of Radiation Oncology, University of Michigan, Ann Arbor, Mich., USA. hsandler@umich.edu
D000230:Adenocarcinoma / Q000532:radiotherapy*; D002986:Clinical Trials as Topic; D015331:Cohort Studies; D003245:Consensus Statements as Topic; D004307:Dose-Response Relationship, Radiation; D006801:Humans; D008297:Male; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D011471:Prostatic Neoplasms / Q000532:radiotherapy*; D011832:Radiation Injuries / Q000453:epidemiology / Q000209:etiology; D011878:Radiotherapy / Q000009:adverse effects; D011879:Radiotherapy Dosage; D012189:Retrospective Studies; D016896:Treatment Outcome